Methoxetamine: Difference between revisions

>Dextromethorphan
No edit summary
>Unity
Changed intro sentence to conform to new standard where we list the substitutive chemical name first. Please follow this standard for all new substance articles as well as for editing old ones.
Line 5: Line 5:
| ''[[Methoxetamine/Summary|Summary sheet: Methoxetamine]]''
| ''[[Methoxetamine/Summary|Summary sheet: Methoxetamine]]''
|}
|}
'''Methoxetamine (MXE)''' or '''3'-MeO-2-Oxo-PCE''', also known as '''Mexxy''' is a synthetic chemical of the [[Chemical class::arylcyclohexylamine]] class which acts as a [[hallucinogenic]] [[psychoactive class::dissociative]].  
'''3'-MeO-2-Oxo-PCE''' (commonly known by the name '''Methoxetamine''', '''MXE''', and also as '''Mexxy''') is a synthetic [[psychoactive class::dissociative]] of the [[Chemical class::arylcyclohexylamine]] class.  


This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other things.
This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other ailments.<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref> It is a chemical derivative of [[ketamine]] that also contains structural features of [[phencyclidine]] (PCP) and [[3-MeO-PCP]].  
<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref> It is a chemical derivative of [[ketamine]] that also contains structural features of [[phencyclidine]] (PCP) and [[3-MeO-PCP]].  
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref>
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref>